4//SEC Filing
Mortenson Mark 4
Accession 0001562180-23-005628
CIK 0001822791other
Filed
Jul 2, 8:00 PM ET
Accepted
Jul 3, 1:49 PM ET
Size
6.0 KB
Accession
0001562180-23-005628
Insider Transaction Report
Form 4
Clene Inc.CLNN
Mortenson Mark
Chief Science Officer
Transactions
- Award
Stock Options (Right to buy)
2023-06-29+800,000→ 800,000 totalExercise: $0.90Exp: 2033-06-29→ Common Stock (800,000 underlying)
Footnotes (1)
- [F1]This option was granted on June 29, 2023 as an option for 800,000 shares of Common Stock under the Clene Inc. Amended 2020 Stock Plan at an exercise price of $0.90 per share. The options vest with respect to the first 25% of such shares on June 29, 2024 and then in 36 equal installments of the balance of the shares of Common Stock on the last day of each calendar month beginning July 29, 2024 until such shares are fully vested. If Clene Inc. has an NDA accepted by the FDA, 50% of the option shares shall vest on that date. If the FDA approves the accepted NDA, the then remaining unvested option shares shall vest on that date.
Documents
Issuer
Clene Inc.
CIK 0001822791
Entity typeother
Related Parties
1- filerCIK 0001835427
Filing Metadata
- Form type
- 4
- Filed
- Jul 2, 8:00 PM ET
- Accepted
- Jul 3, 1:49 PM ET
- Size
- 6.0 KB